Rabbit Recombinant Monoclonal Caspase-5 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 6 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IHC-P | ICC/IF | IP | Flow Cyt | WB | |
---|---|---|---|---|---|
Human | Tested | Not recommended | Tested | Not recommended | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/50 - 1/100 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/50 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Thiol protease that acts as a mediator of programmed cell death (PubMed:28314590, PubMed:29898893). Initiates pyroptosis, a programmed lytic cell death pathway through cleavage of Gasdermin-D (GSDMD): cleavage releases the N-terminal gasdermin moiety (Gasdermin-D, N-terminal) that binds to membranes and forms pores, triggering pyroptosis (PubMed:29898893). Also mediates cleavage and maturation of IL18 (PubMed:37993714). Cleavage of GSDMD and IL18 is not strictly dependent on the consensus cleavage site but depends on an exosite interface on CASP4 (PubMed:37993714). During non-canonical inflammasome activation, cuts CGAS and may play a role in the regulation of antiviral innate immune activation (PubMed:28314590).
ICH3, CASP5, Caspase-5, CASP-5, ICE(rel)-III, Protease ICH-3, Protease TY
Rabbit Recombinant Monoclonal Caspase-5 antibody. Suitable for IHC-P, IP, WB and reacts with Human samples. Cited in 6 publications.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Based on amino acids homology, this antibody will not recognize either p20 or p10 subunits of Caspase-5.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking/Diluting Buffer and concentration:
5% NFDM/TBST
All lanes: Western blot - Anti-Caspase-5 antibody [EP876Y] (ab40887) at 1/1000 dilution
All lanes: HT-1080 (Human fibrosarcoma epithelial cell) prepared in 1%SDS Hot lysis method whole cell lysates at 15 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 47 kDa
Purified ab40887 at 1/50 dilution (2μg) immunoprecipitating Caspase-5 in HeLa treated with heat shock (42? 1h) then recovery for 6h whole cell lysate.
Lane 1 (input): HeLa (Human cervix adenocarcinoma epithelial cell) treated with heat shock (42? 1h) then recovery for 6h whole cell lysate 10μg
Lane 2 (+): ab40887 + HeLa treated with heat shock (42? 1h) then recovery for 6h whole cell lysate.
Lane 3 (-): Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab40887 in HeLa treated with heat shock (42? 1h) then recovery for 6h whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration: 5% NFDM/TBST.
Diluting buffer and concentration: 5% NFDM/TBST.
Observed band size: 47 kDa
All lanes: Immunoprecipitation - Anti-Caspase-5 antibody [EP876Y] (ab40887)
Predicted band size: 50 kDa
Stainign of Caspase 5 on paraffin-embedded human breast carcinoma sections, using ab40557 at a 1/50 dilution. Heat mediated antigen retrieval was performed with citrate buffer pH 6 before commencing with IHC staining protocol.
The cell lysates were prepared in 1%SDS Hot lysis method.
All lanes: Western blot - Anti-Caspase-5 antibody [EP876Y] (ab40887) at 1/10000 dilution
All lanes: HeLa cell lysate at 10 µg
Predicted band size: 50 kDa
Observed band size: 47 kDa
Image collected and cropped by CiteAb under a CC-BY license from the publication
Caspase-5 western blot using anti-Caspase-5 antibody [EP876Y] ab40887. Publication image and figure legend from Zhang, Z., Shao, X., et al., 2018, Cell Death Dis, PubMed 30250284.
ab40887 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab40887 please see the product overview.
Iohexol induces TEC pyroptosis via activation of inflammatory caspases in mice and humans.a ELISA detection of mature IL-1β in human TEC culture supernatants 72 h after TECs treated with iohexol in a dose-dependent manner. b Immunoblot analysis of the inflammatory caspase-11 in mouse TECs and the inflammatory caspases 4/5 in human TECs with extracellular iohexol (20 mg/ml) or isosmotic mannitol for 72 h. c Quantification of the inflammatory caspases expression shows significant upregulation of caspase-11 and caspases 4/5 in mouse and human TECs, respectively. Statistics obtained from ANOVA. d mRNA expression of inflammatory caspases was determined by real-time PCR in human TECs after a 72 h period of iohexol (20 mg/ml) or isosmotic mannitol incubation. e Release of LDH showed that iohexol (20 mg/ml) or isosmotic mannitol incubation for 16 h led to marked cell lysis. Cell lysis was blocked by the pan-caspase inhibitor Z-VAD-FMK. f Incubation with iohexol (20 mg/ml) or isosmotic mannitol for 72 h increased mature IL-1β secretion, measured by ELISA in cell culture supernatants, whereas the response was abrogated by the pan-caspase inhibitor Z-VAD-FMK. Experiments were performed in triplicate. Ctrl, control. **P < 0.01, ***P < 0.001 vs. control or as indicated. Data are means ± SEM. Statistics obtained from ANOVA
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com